Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Zyme Communications

13:28 EDT 14th August 2018 | BioPortfolio

Here are the most relevant search results for "Zyme Communications" found in our extensive news archives from over 250 global news sources.

More Information about Zyme Communications on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Zyme Communications for you to read. Along with our medical data and news we also list Zyme Communications Clinical Trials, which are updated daily. BioPortfolio also has a large database of Zyme Communications Companies for you to search.

Showing News Articles 1–25 of 344 from Zyme Communications

Tuesday 14th August 2018

Expedeon AG adds five new Alexa Fluor labels to its Lightning-Link antibody labeling kit range

New kits enable easy, fast labeling of primary antibodies or proteins with Alexa Fluor 647, 700, 555, 568, and 694 Alexa Fluor fluorescent labels are the most popular labels used within common fluorescence detection based applications Heidelberg, Germany and Cambridge, UK, 14 August 2018 – Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today announced the int...

Monday 13th August 2018

Sphere Fluidics Limited appoints Dr Tris Vaughan as scientific advisor.

Cambridge, UK, 13 August 2018: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today that Tris Vaughan, PhD FRSB has joined its scientific advisory board (SAB). Dr Vaughan’s appointment will further strengthen the company’s understanding of biopharmaceutical discovery and cell line development and help...

Concept Life Sciences appoints Sarah Harris as East Coast Business Development Director - Expands the Group’s integrated drug discovery and development services support within the US.

Manchester, UK, 13 August 2018: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced the appointment of Sarah Harris as Business Development Director for the East Coast, USA. Sarah joins David Halverson, US Head of Sales, and John Vu, West Coast Business Development Director, to further expand the Group’s support fo...

Thursday 2nd August 2018

Mologic commences clinical trial of urine-based diagnostic for cystic fibrosis

Study will evaluate urinary biomarkers associated with onset of pulmonary exacerbations and validate HeadsUp POC diagnostic for patient self-monitoring Bedfordshire, UK, 02 August 2018: Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has commenced a clinical trial to evaluate the Company’s urine-based diagnostic,...

Wednesday 1st August 2018

Breast Cancer Device Receives FDA Approval -The first non-radioactive, dual-tracer for sentinel lymph node biopsy approved in the U.S.

The first non-radioactive, dual-tracer for sentinel lymph node biopsy approved in the U.S. CAMBRIDGE, UK, 1st August 2018 — Endomag, the surgical guidance company, announced that it has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for Magtrace, the first non-radioactive, dual-tracer for lymphatic mapping in patients with breast cancer undergoing a...

Phico Therapeutics awarded Innovate UK funding for £1.4 million ($1.87M) antibacterial therapy project.

Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance CAMBRIDGE, UK, 01 August 2018 – Phico Therapeutics Ltd (‘Phico’), a biotechnology company developing a novel platform technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, today announced that it ...

Irvine Scientific now offers Falcon® IVF products in the United States.

SANTA ANA, CA., August 1, 2018 —Irvine Scientific, a Fujifilm Company, and an industry leader in cell culture media development and manufacturing, today announced a new agreement with Corning Incorporated (NYSE:GLW), which gives Irvine Scientific US distribution rights for Corning’s Falcon® In Vitro Fertilization (IVF) dishes and plates line. Irvine Scientific’s core s...

Tuesday 31st July 2018

Bio-Rad Announces the Launch of Anti-Ranibizumab Antibodies

HERCULES, Calif.–July 31, 2018–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of a range of recombinant monoclonal anti-ranibizumab antibodies that are highly specific for the monoclonal antibody drug ranibizumab (Lucentis) or the complex of ranibizumab with its target, vascular...

Monday 30th July 2018

TTP completes expansion of life sciences lab facility for Desktop Biology programmes.

Dedicated facility developed in response to increasing demand for product development projects in diagnostics, R&D and bioprocess Cambridge, UK, 30 July 2018: TTP plc (TTP), a leading independent technology and product development company, has completed and moved into a new extension of their life sciences development facility.  The additional multi-disciplinary suite of lab space ...

Tuesday 24th July 2018

Avacta Group plc and Tufts University School of Medicine collaborate to develop novel class of drug conjugate

Drug conjugate combines Avacta’s Affimer technology with drug conjugates developed at Tufts Wetherby and Cambridge, UK, 24 July 2018: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has agreed a co-development partnership with Bach BioSciences, a company commercialising the research of William Bachovchin, Profess...

Monday 23rd July 2018

Isogenica Ltd licenses CIS Display Technology to Aro Biotherapeutics for Centyrin-based biopharmaceutical development

Cambridge, UK, 23rd July 2018: Isogenica Ltd today announced that it has signed a new licensing agreement with Aro Biotherapeutics Company (Aro) of Philadelphia. USA, that will leverage each other’s strengths in recombinant protein technologies and biopharmaceutical development. Isogenica is a leader in the design and construction of highly diverse synthetic antibody libraries and the u...

Endomag raises $10 million USD (£8M GBP) to establish a new standard of breast cancer care

Series C funding led by Draper Esprit Brings total funding for Endomag to over $22 million USD (£17M GBP) Investment will be used to expand commercial activity CAMBRIDGE AND LONDON, UK, 23rd July 2018 — Surgical guidance company, Endomagnetics Ltd (Endomag), today announced that it has raised $10 million USD (£8M GBP) Series C funding, led by Draper Esprit. Thi...

Thursday 19th July 2018

Owlstone Medical Appoints Five Leading Experts to Scientific Advisory Board

Additions form a key strategic resource to advise on Breath Biopsy platform, product, and study development Cambridge, UK, July 19 2018: Owlstone Medical (or the “Company”), a diagnostics company developing a breathalyzer for disease, has announced the expansion of its Scientific Advisory Board (SAB) with the appointment of five leading experts in a range of high value disciplin...

Tuesday 17th July 2018

Irvine Scientific Introduces Chemically-defined Natural Killer Cell Expansion Medium for Immunotherapy & Translational Research Applications

The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells SANTA ANA, California—July 17, 2018: Irvine Scientific, an industry leader in the development and manufacture of cell culture media, today announced the introduction of PRIME-XV® NK Cell CDM— the first commercially available chemically-defined (CDM), animal component-free (A...

Monday 16th July 2018

Concept Life Sciences expands integrated drug development services through FEI registration and investment in additional ICH stability capacity.

FEI registration will enable release-testing of pharmaceutical raw materials and finished products for the US market FEI registration allows customers to name Concept Life Sciences as test facility for other regulatory submissions, such as IND 10-fold expansion of Concept’s ICH stability storage accommodates bulkier finished products and builds on its existing full-service of...

Monday 2nd July 2018

Evonetix awarded Innovate UK funding for £1.3 million ($1.75M) gene synthesis project

Funding will support development of a novel enzymatic process for DNA synthesis in collaboration with Durham University CAMBRIDGE, UK, 02 July 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, announced today that it had been awarded substantial funding to support the develop...

IONTAS celebrates 5 years of antibody discovery - Attributes ongoing success to scientific ethos, project management, and innovative research programs

Cambridge, UK, 02 July 2018: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, is celebrating its fifth anniversary. To mark the occasion, the Company held an anniversary party at King’s College, Cambridge, on 30th June 2018, with drinks, dinner and live music. The Company was founded, without external investment, in 2013, by Dr John McCaff...

TTP Plc and Cubed Laboratories announce successful completion of product development project

    NESDEP portable laboratory for pathogen detection is now being transferred for manufacture NESDEP detects pathogens in less than 90 minutes, and aims to provide significant cost savings whilst reducing the incidence of foodborne illnesses Cambridge, UK, 02 July 2018: TTP Plc (TTP), a leading independent technology and product development company, and Cubed Laboratories ...

Thursday 28th June 2018

Owlstone Medical's Breath Biopsy platform scoops the UK’s most prestigious award for engineering innovation

The Royal Academy of Engineering reveals Owlstone Medical as the winners of the 2018 MacRobert Award Cambridge, UK, June 28 2018: Owlstone Medical, a diagnostics company developing a breathalyzer for disease, has announced the team behind the Company’s unique Breath Biopsy® platform has been named the winner of the MacRobert Award 2018 by the Royal Academy of Engineering. Owlstone...

Tuesday 26th June 2018

Concept Life Sciences appoints John Vu as West Coast Business Development Director.

Expands the reach of the Group’s integrated drug discovery and development services in the US Manchester, UK, 26 June 2018: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed John Vu as Business Development Director for the West Coast, to further expand the group’s presence in and support ...

Thursday 21st June 2018

PhoreMost and o2h discovery collaborate to progress first-in-class drug discovery programs.

Cambridge, UK, 21 June 2018: PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage. PhoreMost has built a pipeline of novel...

Tuesday 19th June 2018

Enamine and TBD Biodiscovery collaborate to provide GMP-based services - Collaboration combines expertise in novel chemical compound synthesis with GMP manufacture in drug discovery

Kiev, Ukraine, and Tartu, Estonia, June 19th 2018. Enamine Ltd., a chemical research organization and producer of novel building blocks and screening libraries, and TBD Biodiscovery, a premium GMP manufacturer of fine chemicals including chemical active pharmaceutical ingredients (APIs), today announced they have entered into a collaboration agreement. The partnership aims to manage the trans...

Optibrium Introduces StarDrop 6.5

Novel features include modelling for drug metabolism prediction and virtual library enumeration Enhanced data visualisation environment for more efficient data analysis and project management CAMBRIDGE, UK, 19 June, 2018 – Optibrium™, a developer of software for drug discovery, today announced the launch of version 6.5 of StarDrop™ that provides a complete platform...

Monday 18th June 2018

Avacta Group plc announces the appointment of Dr Eliot Forster as Non-Executive Chairman

Highly experienced pharma/biotech professional to lead Avacta’s Board Wetherby and Cambridge, UK, 11 June 2018: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce the appointment of Dr Eliot Forster as Non-Executive Chairman to the Board with immediate effect.  Dr Trevor Nichols, who has acted as Chairman of the Board ...

Wednesday 13th June 2018

Mologic and Newcastle University launch BReD diagnostic for blackgrass resistance at Cereals

Rapid, one-step, lateral flow test for real-time detection of herbicide resistance in blackgrass Bedfordshire and Newcastle, UK, 13 June 2018: Mologic Ltd, a developer of personalised diagnostics, and Newcastle University, today announced they have developed an on-farm blackgrass resistance diagnostic (BReD). The one-step, rapid lateral flow product for detecting glutathione transferase (Am...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks